CytoMed Therapeutics Ltd
GDTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873093
In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Holders of 5% or more of GDTC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CytoMed Therapeutics Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Choo Chee Kong | 13D/A | 22.05%2.59M shares | −1.12 ppfrom 23.17% | Mar 14, 20252 filings | Oct 29, 2025 | SEC |
| mDR Ltd | 13G/A | 11.33%1.31M shares | – | Mar 24, 20251 filing | Mar 24, 2025 | SEC |
| 28 Consultants Ltd | 13G | 7.62%880.3K shares | New | Mar 4, 20251 filing | Mar 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on CytoMed Therapeutics Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 29, 20254:13 PM ET | Choo Chee Kong | 13D/A | 22.05%2.59M shares | −1.12 ppfrom 23.17% | Oct 29, 2025 | SEC |
| Mar 24, 202512:01 PM ET | mDR Ltd | 13G/A | 11.33%1.31M shares | – | Dec 16, 2024 | SEC |
| Mar 14, 20257:09 PM ET | Choo Chee Kong | 13D/A | 23.17%2.67M shares | – | Feb 20, 2025 | SEC |
| Mar 4, 20253:33 PM ET | 28 Consultants Ltd | 13G | 7.62%880.3K shares | New | Feb 17, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell CytoMed Therapeutics Ltd shares.
No Form 144 notices for CytoMed Therapeutics Ltd are on file.